Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Optical correction of refractive error refers to clinical methods and technologies used to correct refractive errors—conditions where the eye does not focus light properly onto the retina, resulting in blurred vision[5][1]. Common refractive errors include myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia[5][1][6]. Correction approaches include eyeglasses (spectacles), contact lenses, orthokeratology (rigid lenses worn overnight to reshape the cornea), and various forms of refractive surgery (e.g., LASIK, PRK, SMILE), each with its own benefits, limitations, and risks[1][5][6]. These methods do not act on any specific molecular or receptor target, but rather physically alter the optical pathway so that light is correctly focused onto the retina, thus restoring clear vision. Refractive correction is a procedural or device-driven intervention rather than a drug- or molecule-targeted therapy[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Optical correction of refractive error.